SIEMENS HEALTHCARE DIAGNOSTICS, INC. ATELLICA IM PROSTATE-SPECIFIC ANTIGEN (PSA); PROSTATE-SPECIFIC ANTIGEN IMMUNOASSAY
|
Back to Search Results |
|
Model Number N/A |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 12/26/2023 |
Event Type
malfunction
|
Event Description
|
The customer reports observation of an elevated atellica im prostate-specific antigen (psa) result which was discordant relative to clinical expectation and repeat testing.An initial elevated psa result was obtained for a post-prostatectomy patient, and not reported to the physician.The sample was tested two more times, using the same method and instrument, and both repeat tests were lower (near zero), as expected.The result from the third test was accepted as correct.There are no allegations of patient harm, changes in treatment, or delays of diagnosis in association with the observed discordance.
|
|
Manufacturer Narrative
|
A customer from outside the united states reported observation of an elevated atellica im prostate-specific antigen (psa) result which was discordant relative to clinical expectation and repeat testing.There were no issues noted with either calibration or quality control (qc) data.The assay's instructions for use (ifu) states the following, under interpretation of results: "results of this assay should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." siemens healthcare diagnostics is investigating.
|
|
Manufacturer Narrative
|
A customer from outside the united states reported observation of an elevated atellica im prostate-specific antigen (psa) result which was discordant relative to clinical expectation and duplicate repeat testing.No issues were identified with quality control or calibration for the assay, but associated data were not provided for review.Investigation included assessment of available reagent, instrument, and sample data.Reagent issues were ruled out as reproducible results meeting expectation were produced upon repeat testing using the same reagent pack.Instrument log data show no evidence of any hardware issues affecting delivery of any psa reagents, and no evidence of any sample probe issues during aspiration or dispense of the affected sample.Return of the patient sample for further investigation is not warranted because the discordant result was not reproducible.Based on the available information, the root cause cannot be definitively determined, but the issue appears to be an isolated case, and preanalytical variables (sample-quality issues) cannot be ruled out.No product problem was identified.The customer is operational, and no further action is required.
|
|
Search Alerts/Recalls
|
|
|